
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2025 Earnings Call Transcript
MiNK Therapeutics, Inc. (NASDAQ:INKT) Q2 2025 Earnings Call Transcript August 14, 2025 MiNK Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-1.06 EPS, expectations were $-0.55. Operator: Good morning, and welcome to MiNK Therapeutics’ …